Literature DB >> 30991921

Pulmonary delivery of siRNA as a novel treatment for lung diseases.

Rima Kandil1, Olivia M Merkel1.   

Abstract

Graphical abstract.

Entities:  

Keywords:  RNAi; inhalation; lung diseases; pulmonary delivery; siRNA

Mesh：

Substances：

Year:  2019        PMID： 30991921     DOI： 10.4155/tde-2019-0009

Source DB:  PubMed          Journal:  Ther Deliv        ISSN： 2041-5990


  8 in total

Review 1.  Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome.

Authors:  Makhloufi Zoulikha; Qingqing Xiao; George Frimpong Boafo; Marwa A Sallam; Zhongjian Chen; Wei He
Journal:  Acta Pharm Sin B       Date:  2021-08-12       Impact factor: 11.413

2.  Small interfering RNA: a tailored approach to explore the therapeutic potential in COVID-19.

Authors:  Aditya Kiran Gatta; Venkata Rao Josyula
Journal:  Mol Ther Nucleic Acids       Date:  2021-01-21       Impact factor: 8.886

3.  Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes.

Authors:  Domizia Baldassi; Shubhankar Ambike; Martin Feuerherd; Cho-Chin Cheng; David J Peeler; Daniel P Feldmann; Diana Leidy Porras-Gonzalez; Xin Wei; Lea-Adriana Keller; Nikolaus Kneidinger; Mircea Gabriel Stoleriu; Andreas Popp; Gerald Burgstaller; Suzie H Pun; Thomas Michler; Olivia M Merkel
Journal:  J Control Release       Date:  2022-03-29       Impact factor: 11.467

4.  A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant.

Authors:  Yi-Chung Chang; Chi-Fan Yang; Yi-Fen Chen; Chia-Chun Yang; Yuan-Lin Chou; Hung-Wen Chou; Tein-Yao Chang; Tai-Ling Chao; Shu-Chen Hsu; Si-Man Ieong; Ya-Min Tsai; Ping-Cheng Liu; Yuan-Fan Chin; Jun-Tung Fang; Han-Chieh Kao; Hsuan-Ying Lu; Jia-Yu Chang; Ren-Shiuan Weng; Qian-Wen Tu; Fang-Yu Chang; Kuo-Yen Huang; Tong-Young Lee; Sui-Yuan Chang; Pan-Chyr Yang
Journal:  EMBO Mol Med       Date:  2022-02-21       Impact factor: 12.137

5.  Nanoscale Porphyrin Metal-Organic Frameworks Deliver siRNA for Alleviating Early Pulmonary Fibrosis in Acute Lung Injury.

Authors:  Changmei Weng; Guanhua Li; Dongdong Zhang; Zhaoxia Duan; Kuijun Chen; Jieyuan Zhang; Tao Li; Jianmin Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-07-18

Review 6.  Pulmonary Delivery of Emerging Antibacterials for Bacterial Lung Infections Treatment.

Authors:  Jiaqi Li; Huangliang Zheng; Sharon Shui Yee Leung
Journal:  Pharm Res       Date:  2022-09-19       Impact factor: 4.580

Review 7.  Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID).

Authors:  Amir Seyfoori; Mahdieh Shokrollahi Barough; Pooneh Mokarram; Mazaher Ahmadi; Parvaneh Mehrbod; Alireza Sheidary; Tayyebeh Madrakian; Mohammad Kiumarsi; Tavia Walsh; Kielan D McAlinden; Chandra C Ghosh; Pawan Sharma; Amir A Zeki; Saeid Ghavami; Mohsen Akbari
Journal:  Int J Mol Sci       Date:  2021-06-28       Impact factor: 5.923

8.  Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?

Authors:  Gemma Conte; Gabriella Costabile; Domizia Baldassi; Valeria Rondelli; Rosaria Bassi; Diego Colombo; Giulia Linardos; Ersilia V Fiscarelli; Raffaella Sorrentino; Agnese Miro; Fabiana Quaglia; Paola Brocca; Ivana d'Angelo; Olivia M Merkel; Francesca Ungaro
Journal:  ACS Appl Mater Interfaces       Date:  2022-02-02       Impact factor: 9.229
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.